Ophthalmic Trials Australia | Teneriffe, Australia

Research site

Location

2/53 Commercial Rd, Teneriffe, Queensland, Australia

Site insights

Top conditions

Top treatments

AZR-MD-001

RHPRG4

TN-001

KIO-101

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

Mark Hinds

Verified by this site

Active trials

4 of 9 total trials

A PHASE II PROSPECTIVE RANDOMIZED DOUBLE-MASKED CONTROLLED STUDY ASSESSING THE SAFETY & EFFICACY OF RHPRG4 (450 µG/ML RECOMBINANT HUMAN PROTEOGLYCAN 4) COMPARED TO VEHICLE FOR THE TREATMENT OF SJÖGREN'S RELATED DRY EYE DISEASE

rhPRG4-Sjögren's-002 is a prospective multi-center study conducted in Australia to evaluate the safety and efficacy of topically-applied rhPRG4 in su...

Enrolling

Sjögren's Syndrome

Drug: Vehicle Control

Drug: Recombinant Human Proteoglycan 4

A PHASE II PROSPECTIVE RANDOMIZED DOUBLE-MASKED CROSSOVER STUDY ASSESSING THE SAFETY & EFFICACY OF RHPRG4 (450 μG/ML RECOMBINANT HUMAN PROTEOGLYCAN 4) COMPARED TO VEHICLE FOR THE TREATMENT OF OCULAR GRAFT-VERSUS-HOST DISEASE (OGVHD)

An 84-day, prospective, randomized (1:1) vehicle controlled, double-masked pre-market, crossover study. Subjects with moderate to severe oGVHD relate...

Enrolling

Ocular Graft Versus Host Disease

Drug: rhPRG4 450ug/ml

Drug: Vehicle Control

An Evaluation of the Safety and Tolerability of Ocular Lubricants

The purpose of this study is to evaluate the safety and tolerability of two new artificial tear formulations in subjects with moderate dry eye diseas...

Enrolling

Dry Eye Disease

Other: FID123440 test formulation

Other: FID123437 test formulation

Study of TN-001 Topical Eyedrops for Keratoconus

The goal of this clinical trial is to learn if TN-001, a new eye-drop therapy, is safe and well-tolerated in adult patients with progressive keratoco...

Invitation-only

Keratoconus

Drug: High-dose TGF-B3 and Dexamethasone Sodium Phosphate

Drug: Low-dose TGF-B3 and Dexamethasone Sodium Phosphate